BUPRENORPHINE 20 MCG/HR PATCH

buprenorphine
$56.6798per EA
DEA Schedule CIII

Strength

20 ug/h

Manufacturer

Alvogen Inc.

NDC

47781040804

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207490

On Market Since

5/17/2022

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

+7.6%

3M

+5.5%

6M

-2.0%

1Y

-0.1%

3Y

-33.6%

5Y

N/A

All

-40.1%